Traws Pharma, Inc. (TRAW)
NASDAQ·Healthcare·Biotechnology
$1.20
+5.26%
Mkt Cap $7.96M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.00
Range $8.00 – $8.00
Implied Upside
+566.7%
Consensus $8.00 vs current $1.20
NASDAQ·Healthcare·Biotechnology
$1.20
+5.26%
Mkt Cap $7.96M
No recent rating data.
Price Target (1 analysts)
$8.00
Range $8.00 – $8.00
+566.7%
Consensus $8.00 vs current $1.20